Dual power supply switching circuitry for use in a closed system

Information

  • Patent Grant
  • 8929996
  • Patent Number
    8,929,996
  • Date Filed
    Wednesday, March 11, 2009
    15 years ago
  • Date Issued
    Tuesday, January 6, 2015
    10 years ago
Abstract
Optimal power switching circuitry for use in a closed system such as a TET system including an internal device separated from an external device by a boundary. The internal and external devices being powered by separate power sources. During telemetric communication from the external device to the internal device an external RF energy source is produced. If the power supplied by the external RF energy source produced during communication from the external device to the internal device exceeds that required for powering of the internal device, then the power switching circuitry cuts off power to the internal power source and instead draws power from the external RF energy source thereby conserving power consumed from the internal power source. The power switching circuitry may be implemented using either passive components (e.g., diodes) or active components (e.g., an analog switch).
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention is directed to a closed system such as a transcutaneous energy transfer (TET) system and, in particular, to a dual power supply switching system for a TET system wherein powering of an implantable medical device and its associated components is switched, during communication from the external device to the implant, between an internal power source of the implantable medical device and an external RF power source produced by the external device.


2. Description of Related Art


In a variety of scientific, industrial, and medically related applications, it may be desirable to transfer energy or power (energy per unit time) across some type of boundary. For example, one or more devices that require power (e.g., electrical, mechanical, optical, and acoustic devices) may be located within the confines of a closed system, or “body,” in which it may be difficult and/or undesirable to also include a substantial and/or long term source of power. The closed system or body may be delimited by various types of physical boundaries, and the system internal to the boundary may be living or inanimate, may perform a variety of functions, and may have a variety of operational and physical requirements and/or constraints. In some cases, such requirements and constraints may make the implementation of a substantial and/or long term “internal” power source for internally located devices problematic.


In some closed systems, repeated entry into the system may be undesirable for a variety of reasons. In other closed systems, significant internal power requirements and a limited internal space may prohibit the implementation of a suitably sized internal power source. In yet other systems, contamination and/or security issues may pose particular challenges in implementing an internal power source. For any combination of the foregoing and other reasons, a power source external to the system and some feasible means of transferring power from the external source to one or more internal devices may be preferable in some applications.


One common example of a closed system is the human body. In some medically related and scientific applications, a variety of prosthetic and other medical devices that require power may be surgically implanted within various portions of the body. Some examples of such devices include, but are not limited to, drug infusion pumps, pacemakers, defibrillators, cochlear implants, sensors and stimulators. With respect to the human body, issues such as repeated reentry or surgery, internal space limitations, and contamination (e.g., infection) are factors to consider when selecting a suitable internal power source for some of these implantable medical devices.


Accordingly, in some medical implant applications, “transcutaneous energy transfer” (TET) devices are employed to transfer energy from outside the body to inside the body, to provide power to one or more implanted prostheses or devices from an external power source. One example of a conventional TET device is a transformer that includes a primary winding (or coil) external to the body and a secondary winding internal to the body. Both the primary and secondary windings generally are placed proximate to respective outer and inner layers of a patient's skin; hence, the term “transcutaneous” commonly refers to energy transfer “through the skin.” Energy is transferred from the primary winding to the secondary winding in the form of an RF field.


In a system employing an implantable medical device and external control unit each of the implantable medical device and external control unit preferably has its own power source, e.g., a battery, for powering its associated circuitry and its associated components. The implantable medical device battery, regardless of whether primary/non-rechargeable or secondary/rechargeable, has a limited lifespan and a predetermined amount of energy or power before having to be replaced or recharged.


It is therefore desirable to develop and an improved TET system having circuitry for optimally switching from an internal power source to an external RF power source so as to reduce the energy consumed from the internal power source associated with the implant.


SUMMARY OF THE INVENTION

The present invention is directed to TET system that includes circuitry for optimally switching from an internal power source to an external RF power source.


The present invention is directed to TET system that minimizes power consumption of the implantable medical device power source.


One aspect of the invention relates to a closed system such as a TET system having dual power supply switching circuitry. The system includes an internal device disposed interior of a boundary and powered by an internal power source. Disposed separated from the internal device and exterior to the boundary is an external device. The external device is in telemetric communication with the internal device and generates an external RF energy source during telemetric communication with the internal device. Power switching circuitry is used to switch from the internal power source to the external RF energy source during communication from the external device to the internal device when power supplied by the external RF energy source exceeds that required for powering the internal device.


Yet another aspect of the present invention is directed to a method for operating the dual power supply switching circuitry in the system described above. Specifically, the method is realized by generating during communication of the external device with the internal device an external RF energy source. During communication from the external device to the internal device when power supplied by the external RF energy source exceeds that required for powering the internal device, powering of the internal device is switched from the internal power source to the external RF energy source using power switching circuitry.





BRIEF DESCRIPTION OF THE DRAWING

The foregoing and other features of the present invention will be more readily apparent from the following detailed description and drawings of illustrative embodiments of the invention wherein like reference numbers refer to similar elements throughout the several views and in which:



FIG. 1 is a schematic diagram of an exemplary TET system in accordance with the present invention including an external device in telemetric communication with an implantable medical device, wherein the implantable medical device employs passive power switching circuitry;



FIG. 2
a is a schematic diagram of exemplary passive power switching circuitry in FIG. 1;



FIG. 2
b is an exemplary flow diagram of the passive power switching circuitry of FIG. 2a;



FIG. 3
a is a schematic diagram of an exemplary implantable medical device employing active power switching circuitry for use in a TET system; and



FIG. 3
b is an exemplary flow diagram of the active power switching circuitry of FIG. 3a.





DETAILED DESCRIPTION OF THE INVENTION

The present invention is directed to an energy efficient closed system such as a TET system that includes a first internal electronic device in telemetric communication with and separated by a physical boundary by a second external electronic device, wherein each electronic device has its own power source (e.g., battery). By way of example, the TET system and method in accordance with the present invention is shown in FIG. 1 for an implantable drug infusion pump in telemetric communication with an external device, e.g., a control unit or PC. It is to be understood, however, that the present invention may be used for other implantable medical devices or other electronic devices not related to the medical field. The present invention is suitable for any closed system comprising two electronic devices that communicate via telemetric link, wherein the energy used to power the internal device is optimally switched from an internal power source to an external RF source produced by the external device during communication with the internal device.


The exemplary TET system shown FIG. 1 comprises an external device 100 (e.g., a control unit) in telemetric communication with an implantable medical device 105 (e.g., an implantable drug infusion pump). External device 100 includes a primary coil 110 connected to a tuned matching network or circuit 115. A demodulator 150 is connected to the matching network 115 and demodulates the data signal from the received carrier signal. In turn, the demodulator 150 is electrically connected by a microprocessor or controller 140. A transmitter 145 is connected between the microprocessor 140 and matching network 115. All components and circuitry associated with the external device 100 are powered by a primary power source 125. In a preferred embodiment, the power source 125 for powering the external device and its associated circuitry and components is a secondary/rechargeable battery, most preferably a smart rechargeable battery.


The implantable medical device 105 has an associated secondary coil 120 connected to tuned a matching network or circuit 155. A demodulator 160 is connected to the matching network 155 for extracting the data signal from the received carrier signal. Microprocessor 135 is, in turn, connected to the demodulator 160. Electrically connected between the microprocessor 135 and matching network 155 is a modulator 170 for modulating the signal prior to transmission to the external device 100. A secondary or internal power source 130 provides power to all the components and circuitry associated with the implantable medical device. Sometimes the implantable medical device 105 such as an implantable drug infusion pump remains continuously active at all times to maintain operation of the components and circuitry associated therewith. In such applications, the secondary power source 130 is preferably a primary/non-rechargeable battery.


Heretofore, the components and circuitry of the implantable medical device 105 have been powered exclusively by its associated internal power source 130, e.g., battery. During telemetric communication from the external device 100 to the implantable medical device 105 an RF field is generated. This external RF energy source may be used as an alternative source for providing power needed by the implantable medical device 105 and associated circuitry to operate which would otherwise be drawn from the internal battery 130 associated with the implantable medical device. Accordingly, the implantable medical device 105 in accordance with the present invention has been designed to include a high frequency-to-DC converter (HF/DC) 180 and passive power switching circuitry 175 to optimally switch powering of the implantable medical device 105 and its associated components and circuitry from the internal power source 130 to the external RF energy source. Switching between power sources should preferably be instantaneous, automatic and relatively smooth.



FIGS. 2
a & 2b represent schematic and flow diagrams, respectively, of exemplary passive power switching circuitry 175 of FIG. 1 using diodes. By way of example, power switching circuitry 175 is used to switch between an internal battery source 130 associated with the implantable medical device 105 and an external RF energy source emitted by an external device 100 during communication with the implantable medical device. In FIG. 2a, demodulator 160, microprocessor 135 and modulator 170 are generically represented by implant electronics 200. Despite not being shown, the implantable medical device may include additional components as part of the implant electronics 200 depending on the particular functionality of the implant device. For example, an implantable drug infusion pump may include circuitry for controlling the opening and closing of the valve to the reservoir in which the medication is stored.


A first diode 205 is electrically connected between the voltage supply line (Vsupply) and the RF voltage (Vrf), while a second diode 210 is connected between the voltage supply line (Vsupply) and the battery voltage (Vbattery). A capacitor 220 is connected to the voltage supply line (Vsupply) and serves as the stopgap energy supplier during switching of the power supply between Vbattery and Vrf to prevent any interruption in communication.


Typically, the components when powered by the internal battery utilize substantially all the energy in the battery. By way of example, the implantable components may require a minimum of approximately 1.8 V and a maximum of approximately 3.6 V to operate, while the battery voltage is selected to be approximately 2.8 V when fully charged and drops to approximately 1.8 V towards the end of life of the battery. However, a forward voltage drop is experienced across the diode. This drop in voltage will reduce the full range of the battery that is able to power the components. In designing the power switching circuitry it is desirable to select a diode such as a Schottky diode having a relatively low voltage drop, preferably approximately 0.2 V to approximately 0.4 V. Due to the forward voltage drop across the diode the components will operate between approximately 2.8 V and approximately 2.1 V (minimum working voltage of approximately 1.8 V+diode forward voltage drop (e.g., approximately 0.3 V)). Once the battery voltage falls below approximately 2.1 V (minimum working voltage of approximately 1.8 V+the forward voltage drop (e.g., approximately 0.3 V)) the battery will not be able to supply the voltage needed to operate the components. Thus, the full battery range capable of powering the components is reduced by the forward voltage drop across the diode.


In operation, during communication of the external device 100 with the implantable medical device 105, if the power supplied by the external RF energy source exceeds that required to energize the implantable medical device and its associated components, then the second diode 210 is reverse biased and all power is drawn from the external RF power source. When power is drawn from the external RF energy source, a backward or reverse leakage current is exhibited in diode 210 which is detrimental to the battery 130. To circumvent this potentially damaging effect on the battery, a leakage current path is created via a switch 217 connected in series to a resistor 215 whose resistance is lower than that of the battery 130. In the presence of an external RF voltage, switch 217 is closed so that the leakage current flows through the resistor 215 rather than the battery 130.


On the other hand, whenever there is no RF communication or the RF energy emitted during communication from the external device 100 to the implantable medical device 105 is less than or equal to that required to energize the implantable medical device and its associated components, the first diode 205 is reverse biased and all components in the implantable medical device draw power from the battery 130. Thus, switching of the power source used to energize the implantable medical device and its associated components from the battery to the external RF energy source emitted by the external device during communication with the implant will occur only when the power supplied by the emitted RF field exceeds that required to energize the implantable medical device and its associated components. Substantially all the battery potential is typically consumed by the components and associated circuitry of the implantable medical device when powered by the battery 130. Under such circumstances, switching from the internal power source 130 to the external RF power source will take place only when the external RF voltage potential exceeds the battery voltage.


Alternatively, the implantable device may employ active power switching circuitry. FIGS. 3a & 3b show a schematic diagram and flow diagram, respectively, of exemplary active power switching circuitry 190 using an analog switch. In FIG. 3a, implant electronics block 200 generically represents the modulator 170, demodulator 160, microprocessor 135 and any other circuitry associated with the specific functionality of the implant that is not otherwise specifically shown. An analog switch 305 is electrically connected to the RF voltage supply line (Vrf), the battery voltage supply line (Vbattery), and the voltage supply line (Vsupply). Preferably, the analog switch 305 is chosen so as to satisfy the following requirements: relatively low ON resistance; relatively high OFF resistance; relatively low leakage current; relatively low capacitance. In order to bias the internal circuitry, analog switch 305 is continuously powered by the battery 130. Accordingly, as depicted in the flow diagram of FIG. 3b, the battery supply line (Vbattery) is electrically connected to the normally closed (NC) input of the analog switch 305, while the RF voltage supply line (Vrf) is connected to the normally open (NO) input of analog switch 305. The additional drain on the battery in having to continuously power the analog switch increases the overall average current consumption of the components of the implantable medical device.


During RF communication from the external device 100 to the implantable medical device 105, the microprocessor 135 in the implantable medical device determines whether the power supplied by the external RF energy source exceeds that required to energize the implantable medical device and its associated components. If so, microprocessor 135 asserts an enable signal used to trigger analog switch 305 to switch from the internal power source 130 to the external RF energy source. In the absence of RF communication from the external device to the implantable medical device the enable signal from the microprocessor 135 is disabled and the capacitor 220 connected to the Vsupply line is charged automatically from the battery 130. As discussed above, capacitor 220 serves as the stopgap energy supplier while switching from the internal battery to the external RF energy source supplying power to the implantable medical device and its associated components.


Other active components may be employed instead of an analog switch. The use of diodes in accordance with the first embodiment of the invention, however, is preferred over that of the second embodiment using an analog switch due to the increased battery power consumption and larger area footprint on the circuit board when employing an analog switch. Yet still another disadvantage associated with use of an analog switch is that it requires an external logic element (e.g., a microprocessor or controller) for sensing the voltage and controlling the switch. In contrast, the diode configuration is totally passive and not triggered by a microprocessor.


Thus, while there have been shown, described, and pointed out fundamental novel features of the invention as applied to a preferred embodiment thereof, it will be understood that various omissions, substitutions, and changes in the form and details of the devices illustrated, and in their operation, may be made by those skilled in the art without departing from the spirit and scope of the invention. For example, it is expressly intended that all combinations of those elements and/or steps that perform substantially the same function, in substantially the same way, to achieve the same results be within the scope of the invention. Substitutions of elements from one described embodiment to another are also fully intended and contemplated. It is also to be understood that the drawings are not necessarily drawn to scale, but that they are merely conceptual in nature. It is the intention, therefore, to be limited only as indicated by the scope of the claims appended hereto.


Every issued patent, pending patent application, publication, journal article, book or any other reference cited herein is each incorporated by reference in their entirety.

Claims
  • 1. A closed system having dual power supply switching circuitry, comprising: an implantable medical device disposed interior of a boundary;an internal power source for powering the implantable medical device:an external device separated from the implantable medical device by and disposed exterior to the boundary, the external device being in telemetric communication with the implantable medical device and generating an external RF energy source during telemetric communication with the implantable medical device between a primary coil associated with the external device and a secondary coil associated with the implantable medical device; anda first diode electrically connected to draw power from the external RF energy source, and a second diode electrically connected to draw power from the internal power source, the first and second diodes are electrically coupled between the secondary coil and the internal power source for switching from the internal power source to the external RF energy source during communication from the external device to the implantable medical device only when power supplied by the external RI energy source exceeds that required for powering the implantable medical device;wherein the first and second diodes are electrically coupled to a common voltage supply line node; and wherein the first diode is electrically connected between the common voltage supply line node and the external RF energy source, while the second diode is electrically connected between the common supply line node and the internal power source; and the closed system further comprising a capacitor electrically connected directly to an output of each of the first and second diodes to provide power to the implantable medical device while switching the power supply.
  • 2. A method switching of a power supply in a closed system including an internal power source used to power an implantable medical device separated from an external device by a boundary, comprising the steps of: generating an external RF energy source during telemetric communication between a primary coil associated with the external device and a secondary coil associated with the implantable medical device; andduring communication from the external device to the implantable medical device only when power supplied by the external RF energy source exceeds that required for powering the implantable medical device, switching from the internal power source to the external RF energy source using a first diode electrically connected to draw power from the external RF energy source, and a second diode electrically connected to draw power from the internal power source the first and second diodes are electrically coupled between the secondary coil and the internal power source for switching from the internal power source to the external RF energy source during communication from the external device to the implantable medical device only when power supplied by the external RF energy source exceeds that required for powering the implantable medical device;wherein the first and second diodes are electrically coupled to a common voltage supply line node; and wherein the first diode is electrically connected between the common voltage supply line node and the external RF energy source, while the second diode is electrically connected between the common supply line node and the internal power source; and the closed system further comprising a capacitor electrically connected directly to an output of each of the first and second diodes to provide power to the implantable medical device while switching the power supply.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation patent application of U.S. patent application Ser. No. 10/955,678, filed Sep. 30, 2004 (now U.S. Pat. No. 7,720,546, issued on May 18, 2010 ) which is herein incorporated by reference in its entirety.

US Referenced Citations (118)
Number Name Date Kind
3209081 Ducote Sep 1965 A
3229684 Nagumo Jan 1966 A
3357434 Abell Dec 1967 A
3662758 Glover May 1972 A
3888260 Fischell Jun 1975 A
3942535 Schulman Mar 1976 A
4041954 Ohara Aug 1977 A
4071032 Schulman Jan 1978 A
4082097 Mann et al. Apr 1978 A
4102344 Conway et al. Jul 1978 A
4134408 Brownlee et al. Jan 1979 A
4166470 Neumann Sep 1979 A
4172459 Hepp Oct 1979 A
4186749 Fryer Feb 1980 A
4187854 Hepp et al. Feb 1980 A
4373527 Fischell et al. Feb 1983 A
4528987 Slocum Jul 1985 A
4543953 Slocum et al. Oct 1985 A
4561443 Hogrefe et al. Dec 1985 A
4793353 Borkan Dec 1988 A
4941201 Davis Jul 1990 A
4980898 Silvian Dec 1990 A
5113869 Nappholz et al. May 1992 A
5117825 Grevious Jun 1992 A
5229652 Hough Jul 1993 A
5279292 Baumann et al. Jan 1994 A
5314453 Jeutter May 1994 A
5314457 Jeutter et al. May 1994 A
5314458 Najafi et al. May 1994 A
5342408 deCoriolis et al. Aug 1994 A
5358514 Schulman et al. Oct 1994 A
5383912 Cox et al. Jan 1995 A
5411537 Munshi et al. May 1995 A
5422519 Russell Jun 1995 A
5455466 Parks et al. Oct 1995 A
5476488 Morgan et al. Dec 1995 A
5480415 Cox et al. Jan 1996 A
5613935 Jarvik Mar 1997 A
5626630 Markowitz et al. May 1997 A
5690693 Wang et al. Nov 1997 A
5713939 Nedungadi et al. Feb 1998 A
5733313 Barreras, Sr. et al. Mar 1998 A
5735887 Barreras, Sr. et al. Apr 1998 A
5741314 Daly et al. Apr 1998 A
5769877 Barreras, Sr. et al. Jun 1998 A
5876425 Gord et al. Mar 1999 A
5894413 Ferguson et al. Apr 1999 A
5938691 Schulman et al. Aug 1999 A
5991664 Seligman Nov 1999 A
6058330 Borza May 2000 A
6067474 Schulman et al. May 2000 A
6073050 Griffith Jun 2000 A
6114832 Lappi et al. Sep 2000 A
6127799 Krishnan Oct 2000 A
6154677 Leysieffer Nov 2000 A
6239724 Doron et al. May 2001 B1
6275737 Mann Aug 2001 B1
6308101 Faltys et al. Oct 2001 B1
6324430 Zarinetchi et al. Nov 2001 B1
6345203 Mueller et al. Feb 2002 B1
6400991 Kung Jun 2002 B1
6415186 Chim et al. Jul 2002 B1
6445956 Laird et al. Sep 2002 B1
6456883 Torgerson et al. Sep 2002 B1
6458164 Weiss Oct 2002 B1
6505077 Kast et al. Jan 2003 B1
6516227 Meadows et al. Feb 2003 B1
6553263 Meadows et al. Apr 2003 B1
6631296 Parramon et al. Oct 2003 B1
6682480 Habib et al. Jan 2004 B1
6699187 Webb et al. Mar 2004 B2
6819013 Kelly et al. Nov 2004 B2
6870475 Fitch et al. Mar 2005 B2
6894456 Tsukamoto et al. May 2005 B2
6920359 Meadows et al. Jul 2005 B2
6985773 Von Arx et al. Jan 2006 B2
7009362 Tsukamoto et al. Mar 2006 B2
7126310 Barron Oct 2006 B1
7212110 Martin et al. May 2007 B1
7288918 DiStefano Oct 2007 B2
7528094 Blaha et al. May 2009 B2
7561921 Phillips et al. Jul 2009 B2
7565197 Howbrich et al. Jul 2009 B2
7571008 Dinsmoor et al. Aug 2009 B2
7574266 Dudding et al. Aug 2009 B2
7610099 Almendinger et al. Oct 2009 B2
7622988 Denison et al. Nov 2009 B2
7631415 Phillips et al. Dec 2009 B2
7635541 Scott et al. Dec 2009 B2
7641992 Howard et al. Jan 2010 B2
7642013 Howard et al. Jan 2010 B2
7668600 Dudding et al. Feb 2010 B2
7682745 Howard et al. Mar 2010 B2
7699060 Behm Apr 2010 B2
7711433 Davis et al. May 2010 B2
7711435 Schommer May 2010 B2
7715919 Osorio et al. May 2010 B2
7729766 Toy et al. Jun 2010 B2
7738951 Rouw et al. Jun 2010 B2
7761167 Bennett et al. Jul 2010 B2
7815602 Mann et al. Oct 2010 B2
7818180 Riff Oct 2010 B2
7831152 Tatum et al. Nov 2010 B2
7840276 Weispferring et al. Nov 2010 B2
7848819 Goetz et al. Dec 2010 B2
7904167 Klosterman et al. Mar 2011 B2
20010037366 Webb et al. Nov 2001 A1
20030065370 Lebel et al. Apr 2003 A1
20030139783 Kilgore et al. Jul 2003 A1
20030149459 VanArx et al. Aug 2003 A1
20040059392 Parramon et al. Mar 2004 A1
20040176822 Thompson et al. Sep 2004 A1
20050075697 Olson et al. Apr 2005 A1
20050113887 Bauhahn et al. May 2005 A1
20050182459 John et al. Aug 2005 A1
20060020306 Davis et al. Jan 2006 A1
20100023092 Govari et al. Jan 2010 A1
20110022125 Olson et al. Jan 2011 A1
Foreign Referenced Citations (10)
Number Date Country
0472411 Feb 1992 EP
1048324 Feb 2000 EP
1107437 Jun 2001 EP
WO 9837926 Sep 1998 WO
WO 9906108 Feb 1999 WO
WO 9944684 Sep 1999 WO
WO 0001442 Jan 2000 WO
WO 0183029 Nov 2001 WO
WO 0197908 Dec 2001 WO
WO 03033070 Apr 2003 WO
Non-Patent Literature Citations (3)
Entry
Betancourt-Zamora, Rafael J., “The Biolink Implantable Telemetry System,” Integrated Circuits Laboratory—Stanford University (May 1994).
Yu, Hao & Najafi, Khali, “Circutry for a Wireless Microsystem for Neural Recording Microprobes,” Center for Wireless Inegrated MmicroSystems (WIMS), The University of Michigan (Oct. 25, 2001).
Michaud et al., “AZIMUT—a Multi-Modal Locomotion Robotic Platform,” Universite de Sherbrooke—Canada, (Sep. 2003).
Related Publications (1)
Number Date Country
20090228077 A1 Sep 2009 US
Continuations (1)
Number Date Country
Parent 10955678 Sep 2004 US
Child 12381436 US